The Joint Corp. (NASDAQ: JYNT) and Concord Medical Services Holdings Limited (NYSE:CCM) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings.

Institutional and Insider Ownership

47.0% of The Joint Corp. shares are owned by institutional investors. Comparatively, 12.6% of Concord Medical Services Holdings Limited shares are owned by institutional investors. 6.1% of The Joint Corp. shares are owned by company insiders. Comparatively, 46.5% of Concord Medical Services Holdings Limited shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares The Joint Corp. and Concord Medical Services Holdings Limited’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
The Joint Corp. $22.97 million 2.52 -$4.53 million ($0.87) -5.05
Concord Medical Services Holdings Limited $62.26 million 2.80 -$8.29 million ($0.67) -5.97

The Joint Corp. has higher revenue, but lower earnings than Concord Medical Services Holdings Limited. Concord Medical Services Holdings Limited is trading at a lower price-to-earnings ratio than The Joint Corp., indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares The Joint Corp. and Concord Medical Services Holdings Limited’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
The Joint Corp. -48.08% -103.25% -42.06%
Concord Medical Services Holdings Limited N/A N/A N/A

Analyst Recommendations

This is a summary of recent recommendations and price targets for The Joint Corp. and Concord Medical Services Holdings Limited, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Joint Corp. 0 0 4 0 3.00
Concord Medical Services Holdings Limited 0 0 0 0 N/A

The Joint Corp. presently has a consensus price target of $6.15, indicating a potential upside of 40.09%. Given The Joint Corp.’s higher possible upside, research analysts plainly believe The Joint Corp. is more favorable than Concord Medical Services Holdings Limited.

Risk and Volatility

The Joint Corp. has a beta of 1.44, suggesting that its share price is 44% more volatile than the S&P 500. Comparatively, Concord Medical Services Holdings Limited has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500.

Summary

Concord Medical Services Holdings Limited beats The Joint Corp. on 7 of the 12 factors compared between the two stocks.

About The Joint Corp.

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. The Company has approximately 310 franchised, company-owned, or managed clinics in operation in over 30 states. In addition to its approximately 310 operating clinics, the Company has granted franchises either directly or through its regional developers for an additional over 170 clinics. The Company offers a range of membership and wellness packages. Each patient’s records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.

About Concord Medical Services Holdings Limited

Concord Medical Services Holdings Limited is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company is also engaged in hospital operations. The Company’s segments are network and premium cancer hospital. The Company operates a network of radiotherapy and diagnostic imaging centers in China. Its network consists of approximately 130 cooperative centers based in over 70 hospitals, spanning approximately 60 cities across 25 provinces and administrative regions in China. Its network includes approximately 60 radiotherapy centers and over 60 diagnostic imaging centers and approximately seven centers. The Company’s cooperative centers are equipped with a primary unit of medical equipment, such as a linear accelerator, head gamma knife system, body gamma knife system, positron emission tomography-computed tomography (PET-CT) scanner or magnetic resonance imaging (MRI) scanner.

Receive News & Ratings for The Joint Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Joint Corp. and related companies with MarketBeat.com's FREE daily email newsletter.